CardieX (ASX:CDX) ROE % Adjusted to Book Value : -46.95% (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is CardieX ROE % Adjusted to Book Value?

CardieX's ROE % for the quarter that ended in Dec. 2024 was -284.54%. CardieX's PB Ratio for the quarter that ended in Dec. 2024 was 6.06. CardieX's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was -46.95%.

CardieX ROE % Adjusted to Book Value Historical Data

The historical data trend for CardieX's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardieX ROE % Adjusted to Book Value Chart

CardieX Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-19.31

-9.62

-29.57

-109.03

CardieX Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-30.95	-	Negative Equity	-164.64	-46.95

Competitive Comparison of CardieX's ROE % Adjusted to Book Value

For the Medical Devices subindustry, CardieX's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardieX's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CardieX's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where CardieX's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

CardieX ROE % Adjusted to Book Value Calculation

CardieX's ROE % Adjusted to Book Value for the fiscal year that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-693.42%	/	6.36
	=	-109.03%

CardieX's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-284.54%	/	6.06
	=	-46.95%

CardieX ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of CardieX's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

CardieX Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CardieX Ltd (ASX:CDX) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

55 Lime Street, Suite 301, Level 3, Sydney, NSW, AUS, 2000

Website

https://www.cardiex.com

CardieX Ltd is a health technology company, developing solutions for health disorders. The AtCor Medical division develops medical devices for measuring arterial stiffness and central blood pressure waveforms based on its patented SphygmoCor technology. It also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. It reports in a single segment being sales of cardiovascular devices and services to hospitals, clinics, research institutions, and pharmaceutical companies. The company has three reportable segments by geographic area namely the Americas includes, global pharmaceutical trials business, Europe includes, the Middle East and Africa and the Asia Pacific includes, Asia and Australia/New Zealand.